Search results
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 3 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 2 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Combo COVID/flu vaccine elicits higher immune response in trial
United Press International via Yahoo News· 3 days agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is...
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says - WSVN 7News...
7 News Miami· 3 days agoOn Monday, vaccine maker Moderna announced positive late-stage trial results for its Covid-flu...
Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
Yahoo Finance via AOL· 2 days agoThe company said the new combo vaccine provided better protection against both diseases than...
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Investor's Business Daily· 3 days agoMock says Moderna will go to the FDA to determine the path to approval. If approved, this would be...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 16 hours agoThat compares to 55.6% for Keytruda alone. Earlier in the year, one analyst called results from the...
Moderna's COVID-Flu Vaccine Shows Stronger Immune Response Than Individual Shots, Late-Stage Trial...
Forbes· 3 days agoModerna on Monday said its combination COVID-19 and flu shot elicits a stronger immune response...
New COVID Vaccines Targeting JN.1 Will Arrive This Fall
Verywell Health via Yahoo News· 6 days agoStill, he said any of the three vaccine brands would be a good option. “The vaccine is based in...
Moderna to present combo COVID-flu vaccine to regulators after trial
AOL· 3 days agoModerna announced on Monday that its combination COVID-19 and flu mRNA-1083vaccine trial showed "promising" results and that the company would soon present its findings to ...